DE4033524C2 - - Google Patents

Info

Publication number
DE4033524C2
DE4033524C2 DE19904033524 DE4033524A DE4033524C2 DE 4033524 C2 DE4033524 C2 DE 4033524C2 DE 19904033524 DE19904033524 DE 19904033524 DE 4033524 A DE4033524 A DE 4033524A DE 4033524 C2 DE4033524 C2 DE 4033524C2
Authority
DE
Germany
Prior art keywords
bupranolol
butylamino
tolyl
oxy
mammals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE19904033524
Other languages
German (de)
English (en)
Other versions
DE4033524A1 (de
Inventor
Robert Prof. Dr.Rer.Nat. 5303 Bornheim De Mueller
Rainer 4018 Langenfeld De Grund
Edgar Dr.Med.Vet. 4056 Schwalmtal De Fritschi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Pharma GmbH
Original Assignee
UCB Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Pharma GmbH filed Critical UCB Pharma GmbH
Priority to DE4033524A priority Critical patent/DE4033524A1/de
Publication of DE4033524A1 publication Critical patent/DE4033524A1/de
Application granted granted Critical
Publication of DE4033524C2 publication Critical patent/DE4033524C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE4033524A 1990-10-22 1990-10-22 Pharmazeutische verwendung von 1-(tert-butylamino)-3-((6-chloro-m-tolyl)oxy)-2-propanol in einer transdermalen applikationsform Granted DE4033524A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE4033524A DE4033524A1 (de) 1990-10-22 1990-10-22 Pharmazeutische verwendung von 1-(tert-butylamino)-3-((6-chloro-m-tolyl)oxy)-2-propanol in einer transdermalen applikationsform

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4033524A DE4033524A1 (de) 1990-10-22 1990-10-22 Pharmazeutische verwendung von 1-(tert-butylamino)-3-((6-chloro-m-tolyl)oxy)-2-propanol in einer transdermalen applikationsform

Publications (2)

Publication Number Publication Date
DE4033524A1 DE4033524A1 (de) 1992-04-23
DE4033524C2 true DE4033524C2 (sk) 1992-08-20

Family

ID=6416790

Family Applications (1)

Application Number Title Priority Date Filing Date
DE4033524A Granted DE4033524A1 (de) 1990-10-22 1990-10-22 Pharmazeutische verwendung von 1-(tert-butylamino)-3-((6-chloro-m-tolyl)oxy)-2-propanol in einer transdermalen applikationsform

Country Status (1)

Country Link
DE (1) DE4033524A1 (sk)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482533A (en) * 1982-01-11 1984-11-13 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing propranolol
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
GB8629639D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
JPS6468316A (en) * 1987-09-08 1989-03-14 Teikoku Seiyaku Kk External plaster containing salbutamol
DE3843557A1 (de) * 1988-12-23 1990-06-28 Beiersdorf Ag Transdermales therapeutisches system zur verabreichung von clenbuterol

Also Published As

Publication number Publication date
DE4033524A1 (de) 1992-04-23

Similar Documents

Publication Publication Date Title
EP0648114B1 (de) Liposomen, verfahren zu ihrer herstellung und ihre verwendung zur herstellung eines arzneimittels
EP0343694B1 (de) Mittel zur Behandlung und zum Schutz der Haut
DE69636308T2 (de) Tumornekrosefaktor alpha (tnf-alpha) hemmende arzneistoffe
DE60028978T2 (de) Ophthalmische zusammensetzung enthaltend antibiotika und nsaids
DE3734835A1 (de) Arzneimittel zur ophthalmologischen anwendung
EP0204987B1 (de) Vitamin E-haltiges Mittel zur Verbesserung der Eigenschaften des Blutes
DE10361022A1 (de) Topische Zubereitungen enthaltend Dimethylsulfoxid und Dexpanthenol
DE69734405T2 (de) Verwendung von CS-866 (Olmersartan) zur Herstellung eines Medikaments für die Behandlung von Arteriosklerose
EP0413171A1 (de) Mittel zur Behandlung von schweren Schmerzzuständen und Verfahren zu ihrer Herstellung
EP1569724B1 (de) Formulierungen enthaltend melatonin, ginkgo biloba und biotin
US20040131693A1 (en) Composition with a base of a therapeutically active compound, in particular honey, for the treatment of wounds
DE69902520T2 (de) Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
WO1989006962A1 (en) Silver sulfadiazine-containing agent for topical external therapy
EP0163924B1 (de) Vitaminhaltiges Mittel zur Behandlung und zum Schutz der Schleimhäute sowie Verwendung von Vitamin E zur Herstellung des Mittels
EP0214620A2 (de) Transdermale Applikationsform von Diltiazem
DE69907509T2 (de) Pphospholipidkomplexe von proanthocyanidin a2 als antiatherosklerotische mittel
DE69328792T2 (de) Behandlung von migräne
DE4033524C2 (sk)
DE3640409C2 (sk)
DE69227324T2 (de) Pharmazeutische zusammensetzung, die carbachol und andere cholinerge substanzen enthält
DE2514335B2 (de) Oral zu verabreichendes Arzneimittel mit Antiplasmin-Inhibitorwirkung
KR940013503A (ko) 동맥경화증의 예방 또는 치료용 약제학적 조성물
DE69328102T2 (de) Verwendung von gift aus hautflüglern (hymenopteren) zur herstellung eines medikamentes zur behandlung von infektionen durch dna-viren
DE69424679T2 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
AT403434B (de) Topische zusammensetzung zur beschleunigung der wundheilung

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
D2 Grant after examination
8364 No opposition during term of opposition
8330 Complete disclaimer